{"id":5459,"date":"2022-05-04T16:22:26","date_gmt":"2022-05-04T14:22:26","guid":{"rendered":"http:\/\/stiftkgj.webforslag.com\/senter\/k-g-jebsen-senter-for-b-cellekreft\/"},"modified":"2023-06-27T10:28:11","modified_gmt":"2023-06-27T08:28:11","slug":"k-g-jebsen-center-for-b-cell-malignancies","status":"publish","type":"senter","link":"https:\/\/stiftkgj.no\/en\/senter\/k-g-jebsen-center-for-b-cell-malignancies\/","title":{"rendered":"K.G. Jebsen Center for B-cell Malignancies"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row css=&#8221;.vc_custom_1651580050061{margin-right: 0px !important;margin-left: 0px !important;background-image: url(https:\/\/stiftkgj.no\/wp-content\/uploads\/2022\/04\/Topp-bilde-2.jpg?id=427) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}&#8221;][vc_column]<div class=\"spacer-5830a5ea62c1f2880975a2ceab4a96be2\" style=\"\"><\/div><style>@media (min-width: 320px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 200px;}}@media (min-width: 767px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 200px;}}@media (min-width: 979px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 400px;}}@media (min-width: 1200px) { .spacer-5830a5ea62c1f2880975a2ceab4a96be2{ height: 400px;}}<\/style>[\/vc_column][\/vc_row][vc_row el_class=&#8221;article-white&#8221; css=&#8221;.vc_custom_1649536549777{margin-right: 0px !important;margin-left: 0px !important;}&#8221;][vc_column][vc_row_inner][vc_column_inner]<div class=\"spacer-f96c97828f0d47b1724343c705ecae9d423\" style=\"\"><\/div><style>@media (min-width: 320px) { .spacer-f96c97828f0d47b1724343c705ecae9d423{ height: 10px;}}@media (min-width: 767px) { .spacer-f96c97828f0d47b1724343c705ecae9d423{ height: 10px;}}@media (min-width: 979px) { .spacer-f96c97828f0d47b1724343c705ecae9d423{ height: 10px;}}@media (min-width: 1200px) { .spacer-f96c97828f0d47b1724343c705ecae9d423{ height: 10px;}}<\/style><div class=\"header left  \"><h1 class=\"font-size-sm\" title=\"K.G. Jebsen Center for B-cell Malignancies\" style=\"color:#0054a2\">K.G. Jebsen Center for B-cell Malignancies<\/h1><\/div>[\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=&#8221;3\/4&#8243;]\n\t\t\t<figure  class=\"standard-image left no-caption\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"725\" height=\"485\" src=\"https:\/\/stiftkgj.no\/wp-content\/uploads\/2022\/05\/ludvig-munthe-4-e1519117417858.jpg\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/stiftkgj.no\/wp-content\/uploads\/2022\/05\/ludvig-munthe-4-e1519117417858.jpg 725w, https:\/\/stiftkgj.no\/wp-content\/uploads\/2022\/05\/ludvig-munthe-4-e1519117417858-300x201.jpg 300w, https:\/\/stiftkgj.no\/wp-content\/uploads\/2022\/05\/ludvig-munthe-4-e1519117417858-320x214.jpg 320w, https:\/\/stiftkgj.no\/wp-content\/uploads\/2022\/05\/ludvig-munthe-4-e1519117417858-420x281.jpg 420w, https:\/\/stiftkgj.no\/wp-content\/uploads\/2022\/05\/ludvig-munthe-4-e1519117417858-576x385.jpg 576w\" sizes=\"auto, (max-width: 725px) 100vw, 725px\" \/>\n\t\t\t\t\n\t\t\t<\/figure>[vc_column_text]The centre will address the unmet clinical need for patients with B-cell malignancies.<\/p>\n<p>We aim to expand the biological understanding of B-cell malignancies and translate advances into improved patient treatment.<\/p>\n<p>We also aim to improve treatment choices, provide drug sensitivity diagnostics, identify new therapeutic targets, and implement novel treatments in clinical trials.<\/p>\n<p>We will inform users of current knowledge and available treatment options.<\/p>\n<p>The Centre is headed by Professor Ludvig Munthe and comprises two nodes at the Oslo University Hospital (OUH). We are situated at OUH-Rikshospitalet and OUH-Radiumhospitalet and are part of the Medical Faculty\u2019s Institute of Clinical Medicine.[\/vc_column_text]<div class=\"header left  \"><span class=\"font-size-xxs\" title=\"Center leaders\" >Center leaders<\/span><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Ludvig A. Munthe\" style=\"color:#0054a2\">Ludvig A. Munthe<\/span><div class=\"subheader\"><p>Center leader, professor, Department for Immunology, Institute of Clinical Medicine, UiO og OUS.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"June H. Myklebust\" style=\"color:#0054a2\">June H. Myklebust<\/span><div class=\"subheader\"><p>Deputy leader, associate professor, Institute of Clinical Medicine UiO og Seksjon for Kreftimmunologi, Institutt for Kreftforskning, OUS.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xxs\" title=\"Prosjektledere\" >Prosjektledere<\/span><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Hilde Schjerven\" style=\"color:#0054a2\">Hilde Schjerven<\/span><div class=\"subheader\"><p>researcher, Department of Immunology, OUS<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Kjetil Task\u00e9n\" style=\"color:#0054a2\">Kjetil Task\u00e9n<\/span><div class=\"subheader\"><p>professor, Institute of Clinical Medicine and section leader at Institutt for Kreftforskning, OUS.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Erlend B. Smeland\" style=\"color:#0054a2\">Erlend B. Smeland<\/span><div class=\"subheader\"><p>professor, Institute of Clinical Medicine, UiO og Seksjon for Kreftimmunologi, Institutt for Kreftforskning, OUS.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Harald Holte\" style=\"color:#0054a2\">Harald Holte<\/span><div class=\"subheader\"><p>chief physician ved Kreftklinikken, Avdeling for onkologi, OUS-Radiumhospitalet.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Geir E. Tj\u00f8nnfjord\" style=\"color:#0054a2\">Geir E. Tj\u00f8nnfjord<\/span><div class=\"subheader\"><p>professor, chief physician, Avdeling for blodsykdommer, Institute of Clinical Medicine UiO og OUS.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Anders Tveita\" style=\"color:#0054a2\">Anders Tveita<\/span><div class=\"subheader\"><p>researcher, Department of \u00a0Immunology, OUS.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Britt Nakken\" style=\"color:#0054a2\">Britt Nakken<\/span><div class=\"subheader\"><p>researcher, Department of \u00a0Immunology, Institute of Clinical Medicine, UiO.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Alexander Foss\u00e5\" style=\"color:#0054a2\">Alexander Foss\u00e5<\/span><div class=\"subheader\"><p>chief physician at Kreftklinikken, Avdeling for onkologi, OUS-Radiumhospitalet.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Fredrik Schjesvold\" style=\"color:#0054a2\">Fredrik Schjesvold<\/span><div class=\"subheader\"><p>chief physician, Avdeling for blodsykdommer, OUS<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"Ludvig A. Munthe\" style=\"color:#0054a2\">Ludvig A. Munthe<\/span><div class=\"subheader\"><p>Center leader, professor, Department of immunology, Institute of Clinical Medicine, UiO og OUS.<\/p><\/div><\/div><div class=\"header left  \"><span class=\"font-size-xss\" title=\"June H. Myklebust\" style=\"color:#0054a2\">June H. Myklebust<\/span><div class=\"subheader\"><p>Deputy leader, associate professor, Institute of Clinical Medicine UiO og Seksjon for Kreftimmunologi, Institutt for Kreftforskning, OUS<\/p><\/div><\/div><div class=\"header left  \"><h2 class=\"font-size-sm\" title=\"Mediaomtale\" >Mediaomtale<\/h2><\/div><div class=\"external-links-container light-blue\"><ul class=\"external-links\"><li class=\"inner-item\"><i class=\"fa fa-external-link\"><\/i><a href=\"https:\/\/www.med.uio.no\/klinmed\/om\/aktuelt\/aktuelle-saker\/2018\/kg-jebsen-senter-for-b-cellekreft.html\" target=\"_blank\" rel=\"noopener\">UiO.no<\/a><span class=\"description\">MED f\u00e5r nytt Jebsensenter ved Klinmed<\/span><span class=\"date\">15.02.2018<\/span><\/li><\/ul><\/div>[\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;]<div class=\"infobox light-brown\"><h3>About the Center<\/h3>\n<div class=\"wpb_text_column wpb_content_element \">\n<div class=\"wpb_wrapper\">\n<p id=\"hdr\">Leader:\u00a0<a href=\"https:\/\/www.med.uio.no\/klinmed\/personer\/vit\/ludvig\/index.html\" target=\"_blank\" rel=\"noopener\">Professor Ludvig A. Munthe<\/a><br \/>\nStart up: 2018<br \/>\nHost institution: University of Oslo<br \/>\nFunding: 18 + 9 MNOK<br \/>\n<a href=\"https:\/\/www.med.uio.no\/klinmed\/english\/research\/centres\/kgj-b-cell-malignancies\/index.html\" target=\"_blank\" rel=\"noopener\">Homepage<\/a><\/p>\n<\/div>\n<\/div>\n<\/div><div class=\"infobox light-brown\"><h3>Contact information<\/h3><p><strong class=\" elm-has-own-text\">K. G. Jebsen Center for B-cell Malignancies<br \/>\n<\/strong><\/p>\n<p>Post:<br \/>\nAdministrasjonen<br \/>\nInstitutt for klinisk medisin, UiO<br \/>\nOUS-HF Rikshospitalet<br \/>\nPostbox 4950 Nydalen<br \/>\n0424 Oslo<br \/>\nNorway<\/p>\n<p>Visiting Address:<br \/>\n2. etasje A-bygget<br \/>\nOUS Rikshospitalet<br \/>\nSognsvannsveien 20<br \/>\n0372 Oslo<\/p>\n<p>og<\/p>\n<p>Kreftforskningsbygget<br \/>\nOUS Radiumhospitalet<br \/>\nUllernchausseen 70<br \/>\n0372 Oslo<\/p>\n<p>E-post:\u00a0<a href=\"mailto:%20ludvig@medisin.uio.no\">Professor Ludvig A. Munthe<\/a><\/p>\n<p>Telefon: +47 23073500 (sentralbord)<\/p><\/div>[\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column]<div class=\"spacer-19ba46bd32479517faefa95d8bc53e873425752342356\" style=\"\"><\/div><style>@media (min-width: 320px) { .spacer-19ba46bd32479517faefa95d8bc53e873425752342356{ height: 30px;}}@media (min-width: 767px) { .spacer-19ba46bd32479517faefa95d8bc53e873425752342356{ height: 30px;}}@media (min-width: 979px) { .spacer-19ba46bd32479517faefa95d8bc53e873425752342356{ height: 60px;}}@media (min-width: 1200px) { .spacer-19ba46bd32479517faefa95d8bc53e873425752342356{ height: 60px;}}<\/style>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>The centre will address the unmet clinical need for patients with B-cell malignancies. [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary vidiflex-read-more-link\" href=\"https:\/\/stiftkgj.no\/en\/senter\/k-g-jebsen-center-for-b-cell-malignancies\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"featured_media":521,"template":"","categories":[39],"class_list":["post-5459","senter","type-senter","status-publish","has-post-thumbnail","hentry","category-medical-research-old"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/senter\/5459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/senter"}],"about":[{"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/types\/senter"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/media\/521"}],"wp:attachment":[{"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/media?parent=5459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stiftkgj.no\/en\/wp-json\/wp\/v2\/categories?post=5459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}